Approximately 29% of Infants Receive RSV Immunization in the 2023-2024 Season
In the 2023-2024 season, nearly 30% of infants in the U.S. received RSV protection via vaccination or monoclonal antibodies, highlighting ongoing efforts to combat severe respiratory infections in newborns.
During the 2023-2024 respiratory virus season, about 29% of infants born between October 2023 and March 2024 in 33 U.S. states and the District of Columbia were immunized against respiratory syncytial virus (RSV). This coverage includes vaccinations administered through infant receipt of nirsevimab and maternal RSV vaccination during pregnancy. Researchers from the CDC, led by Ellen O. Boundy, estimated that 19% of infants received nirsevimab, a monoclonal antibody, while 10% were vaccinated maternally. Notably, 38% of infants given nirsevimab received it within the first week of life. The variation in immunization coverage among states ranged from 11% to 53%. These efforts aim to enhance protection for infants against severe RSV disease, although experts emphasize the need for increased immunization initiatives to better safeguard this vulnerable population.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Fentanyl Alone Responsible for Majority of Youth Overdose Deaths from 2018 to 2022, Study Finds
A new study highlights that fentanyl alone was responsible for the majority of youth overdose deaths between 2018 and 2022, with a 168% increase over five years. Public health strategies must adapt to these evolving risks.
Lower Sleep Durations Increase Risks for Young Adults During Work and Driving
New research from Murdoch University reveals that multiple sleep disorders, insufficient sleep, and shift work significantly increase the risk of accidents among young adults, emphasizing the importance of comprehensive sleep health strategies.
Underused Blood Conservation Technique Significantly Reduces Transfusion Needs in Heart Surgery
A new study shows that acute normovolemic hemodilution (ANH) can reduce blood transfusion needs in heart surgery by 27%, offering a cost-effective and safer blood management strategy.
Preventing Postoperative Delirium: Low-Cost Strategies to Protect Brain Health
New research reveals that postoperative delirium, a common complication in older surgical patients, is preventable through simple, low-cost interventions that can improve outcomes and reduce healthcare costs.